.

What's Hot in Workers' Comp

TOP 10 DEVELOPMENTS IN DELAWARE WORKERS’ COMPENSATION IN 2023

What’s Hot in Workers’ Comp, Vol. 27, No. 12, December 2023

December 1, 2023

by Benjamin K. Durstein

1.    Supreme Court holds an employer or workers’ compensation carrier may assert a subrogation lien against an employee’s recovery of benefits under an employer-purchased UIM policy, overruling its own precedent, Simendinger v. National Union Fire Insurance.
Horizon Services v. Henry, --- A.3d ---, 2023 WL 5659812 (Del. Sep. 1, 2023)

In September 2015, Mr. Henry was injured in a compensable industrial accident and received over $584,000 in workers’ compensation benefits. He sought damages from the non-party tortfeasor and settled at the $50,000 liability insurance policy limits. The workers’ compensation carrier received reimbursement for its lien from those proceeds after an attorney fee was deducted. Mr. Henry then filed claims for UIM coverage with both his personal policy and the employer’s policy. When those claims were denied, he filed actions against the UIM insurers in Superior Court. The employer and its workers’ compensation carrier moved to intervene in those proceedings, but the motion was denied.

In response, the employer/workers’ compensation carrier filed a declaratory judgment action in Superior Court that asserted entitlement to a lien against any recovery of damages in the UIM action pursuant to 19 Del. C. § 2363(e). The court granted the UIM insurer’s motion for judgment on the pleadings. The judge reasoned that Section 2363(e) limited the right to reimbursement of workers’ compensation benefits for the employer/ workers’ compensation carrier to damages recovered from the non-party tortfeasor, according to the Supreme Court’s holding in Simendinger v. National Union Fire Insurance. The employer/workers’ compensation carrier appealed.

On appeal, the Supreme Court overruled Simendinger and held that Section 2363 permits an employer or workers’ compensation carrier to assert a subrogation lien against an employee’s recovery of benefits under an employer-purchased UIM policy. The court explained that the Simendinger court relied on dictum from an earlier Supreme Court opinion, Hurst v. Nationwide Mutual Insurance Co., to reach its conclusion. However, the Hurst court mistakenly construed the 1993 amendment to Section 2363(e) as eliminating an employer’s ability to obtain a lien against benefits paid under an employer-purchased UIM policy. The actual effect of the amendment was limited to PIP eligible benefits. An employer’s right to lien reimbursement from a UIM recovery was not changed by the amendment. The court explained that Section 2363 does not preclude the workers’ compensation lien against employer-funded UIM benefits. In fact, it expressly allows it. Accordingly, Simendinger was overruled, and the decision below was reversed. However, it could not be determined from the record whether the language of the UIM policy, itself, precluded assertion of the lien. Therefore, the case was remanded to develop the record and consider the contractual arguments of all parties.

2.    The Superior Court affirmed an Industrial Accident Board decision that concluded that a COVID-19 workplace exposure at a poultry processing plant did not qualify as a compensable occupational disease.
Fowler v. Perdue Farms, 2023 WL 6888918 (Del. Super. Oct. 18, 2023)

Mr. Fowler alleged that he suffered a compensable COVID-19 exposure while working as a “boxer” at a poultry processing plant. The Industrial Accident Board (IAB) determined that the claimant carried his burden to prove that he more likely than not contracted COVID-19 in the cafeteria at work. However, the claimant did not prove that his occupation attached a hazard of COVID-19 greater than that attendant to employment in general. The claimant appealed to the Superior Court.

The Supreme Court established the legal standard to determine whether there is a compensable occupational disease in Air Mod v. Newton and Anderson v. General Motors Corp. Air Mod defined a compensable occupational disease as “one resulting from the peculiar nature of the employment, i.e., from working conditions which produce the disease as a natural incident of the particular occupation, attaching to that occupation a hazard different from, and in excess of, the hazards attending employment in general.” The Anderson court opined that the disease cannot result from the “stimuli of the everyday world and that [t]here must be a recognizable link between the disease and some distinctive feature of the claimant’s job.”

In Mr. Fowler’s case, the court agreed with the IAB that the evidence showed that the cafeteria at Perdue presented a greater hazard than that attending employment in general. However, the hazard was not distinct from that attending employment in general. The court cited reasoning decisions from the Ohio Court of Appeals to emphasize that COVID-19 is a disease of everyday life to which the public is exposed. The Workers’ Compensation Act should not be transformed into a health insurance statute. Large cafeterias or gatherings at work are a hazard attending employment in general. Mr. Fowler’s job as a boxer in a chicken plant did not predispose him to COVID-19 more than any other occupation. Lastly, the court opined that there was substantial evidence in the record to support the IAB’s decision. The decision of the IAB was affirmed.

3.    The Superior Court affirmed a decision of the Industrial Accident Board that set aside a workers’ compensation agreement pursuant to Superior Court Civil Rule 60(b) due to fraud on the part of the claimant.
Mendoza v. Talarico Building Servs., 2023 WL 2726923 (Del. Super. Ct. Mar. 30, 2023)

Mr. Mendoza, a non-English speaker, fell at work while cleaning and buffing floors on July 16, 2018. The event was witnessed by a supervisor. The employer acknowledged soft tissue injuries to the neck and back and paid workers’ compensation benefits, including medical expenses. Mr. Mendoza was involved in a subsequent motor vehicle accident in August 2018 and taken by ambulance to the hospital for neck pain. The claimant later underwent a three-level cervical fusion surgery performed by Dr. Zaslavsky, which the employer denied was reasonable, necessary or causally related to the work accident. In response, Mr. Mendoza filed a Petition to Determine Additional Compensation Due, sought compensability of the surgery and total disability benefits. The employer filed a Petition for Review that sought to set aside the original agreement on the basis of fraud and to bar the claimant from future filings against the employer. The petitions were consolidated and heard together.

At the hearing, evidence was provided that showed Mr. Mendoza had a 20-year history of medical treatment for the cervical spine and that he failed to disclose that history to his employer at the time of hire, to the employer/carrier at the time of his accident, to the DME doctor and to Dr. Zaslavsky. The Industrial Accident Board (IAB) concluded that the claimant failed to meet his burden to establish compensability of the cervical spine surgery and found the testimony of Dr. Gelman, the employer’s expert, more persuasive than Dr. Zaslavsky’s. Further, the IAB determined that the claimant had committed fraud due to his failure to disclose the extensive medical history. The underlying agreement was struck, but because there was a witnessed event and little evidence was before the IAB regarding the accepted lumbar spine injury, the claimant was permitted 60 days to file a new petition to attempt to establish compensability of the work accident as pertained to other issues.

The claimant appealed and contended that there was not substantial evidence to support the IAB’s conclusions, and that the IAB erred in its application of Superior Court Civil Rule 60(b) because it did not establish the reliance or damages prongs necessary to find fraud. The court found there was substantial evidence to deny the petition based on Dr. Gelman’s testimony.

For the fraud finding, the court determined that the IAB properly applied Rule 60(b) in this scenario. There was detrimental reliance established because the employer presented evidence that it would not have hired him or accepted the claim if he had been truthful about his prior medical history. Moreover, the IAB did consider damages when it specifically referenced a credit attributable to all the past benefits paid. The court went a step further and advised that this set of facts also qualified to re-open the agreement and set it aside on the basis of Rule 60(b)(3) due to Mr. Mendoza’s “misrepresentation and misconduct.” He had admitted to dishonesty at the hearing and the misrepresentations were not the result of the language barrier, as they were made in response to both English and Spanish inquiries. The decision of the IAB was affirmed.

4.    Superior Court affirms decision denying claimant’s petition for increased medical bill payments for ketamine infusions under the theory that the Delaware Fee Schedule did not apply and the Industrial Accident Board should order payment of the “reasonable cost” of the treatment.”
Taylor v. State of Delaware, N22A-09-007 CLS (Del. Super. Ct. Aug. 14, 2023)

Ms. Taylor was injured in a compensable work accident on September 16, 2016. The injury later developed into Complex Regional Pain Syndrome (CRPS) involving her right arm and right leg. She received ketamine infusion treatments for the CRPS condition that were performed at a surgery center in Pennsylvania. The employer did not contest that the treatment was reasonable, necessary, and causally related and made payments to the surgery center. Ms. Taylor filed a petition, alleging the payments were not sufficient to reimburse such a complicated procedure and not consistent with the Workers’ Compensation Act. The Industrial Accident Board (IAB) determined that the employer correctly reimbursed the surgery center in accordance with the Delaware Workers’ Compensation Fee Schedule (summarized in October 2022 What’s Hot newsletter).

On appeal, the claimant argued that the IAB committed legal error when it failed to exercise its jurisdiction over the amount to be paid and determined that the “reasonable cost” provision of 19 Del. C. § 2322(b) did not apply and control reimbursement in this case. The Superior Court first determined that the IAB properly exercised its jurisdiction and correctly noted that a change to fee schedule reimbursement amounts could not be achieved by the IAB decision. The court distinguished the Quaile v. National Tire and Battery opinion because, unlike in Quaile, there was no “refusal/denial” of treatment to trigger Section 2322(b) in this case. Rather, the employer had accepted the treatment and paid for it correctly as required by Section 2322B(7)b’s provision directed towards reimbursement of out-of-state providers. Accordingly, Ms. Taylor was not forced to seek and pay for medical treatment herself. The Workers’ Compensation Act prohibited the medical provider from seeking payment from Ms. Taylor for charges above those authorized by the health care payment system.

The court held that the “reasonable cost” of the treatment did not apply and there was no legal error by the IAB. The IAB decision was affirmed. The Superior Court order is currently on appeal to the Delaware Supreme Court.

5.    Supreme Court affirmed decision that medical expert causation opinion was substantial evidence and five-year statute of limitations applied to Petition for Additional Compensation Due for new injury/body part related to accepted work accident. 
Elzufon, Austin, Tarlov & Mondell, P.A. v. Lewis, --- A.3d ---, 2023 WL 8382873 (Del. Dec. 5, 2023)

Ms. Lewis injured her right shoulder injury due to the repetitive use of the right arm. The manifestation date of the condition was August 29, 2016. The shoulder ultimately required surgery in 2018. After the surgery, the claimant returned to work in late 2018, but began to experience neck problems. She treated for the new neck issues in 2019. On April 1, 2021, Ms. Lewis filed a petition, alleging that she had injured her neck due to the right shoulder surgery and her post-op rehabilitation efforts. The employer argued that the petition should be dismissed because the allegation was for a “new injury” and more than two years had passed since the 2016 work injury. The Industrial Accident Board (IAB) denied the motion and explained that the applicable statute of limitations for an accepted accident is five years. The IAB also said that, alternatively, the petition was filed within two years of the date the claimant reasonably should have known the condition was related to her work injury, so it also complied with the cumulative detrimental effect statute of limitations. 

At the hearing, the claimant’s expert, Dr. Newell, testified that he believed the circumstances showed that the shoulder surgery had caused a cervical radiculopathy. However, he conceded on cross-examination that he did not have any medical records or documents to support that contention. The employer’s expert testified there was no objective evidence of a cervical radiculopathy and nothing linking a cervical spine injury to the 2016 event. The IAB agreed with Dr. Newell and found the neck injury was causally related to the 2016 accident. The Superior Court affirmed the decision of the IAB, finding substantial evidence, and that the petition was filed within the applicable statute of limitations.

On appeal to the Supreme Court, the employer made two main arguments. First, that the claimant’s medical expert offered a purely speculative opinion that could not constitute substantial evidence and, secondly, again, that the two-year statute of limitations applied and the April 2021 petition was not timely.

The Supreme Court held that Dr. Newell’s opinions were supported by substantial evidence because he was the treating physician; he explained how shoulder surgeries can cause neck problems; the cervical injections helped—which was evidence there was a radiculopathy; and the timing of the neck complaints following the surgery lined up with his opinions. The decision was supported by substantial evidence. Further, the court explained that the five-year statute of limitations applied as this was an accepted claim. For that reason, there was no need to address the IAB’s alternative ruling that the claim was also within the two-year cumulative detrimental effect statute of limitations. The Superior Court opinion was affirmed.

6.    Superior Court affirmed decision terminating total disability benefits and rejected argument that the Industrial Accident Board “precedent” requires DME doctor to examine claimant following a subsequent, intervening event in order to offer an opinion on work capabilities.
Hooten v. Blue Hen Disposal, 2023 WL 1433129 (Del. Super. Ct. Feb. 1, 2023)

Mr. Hooten injured his neck in a compensable work accident in December 2020. In late 2021, the employer filed a Petition to Terminate ongoing total disability benefits based on the opinions of Dr. Gelman. While the petition was pending, the claimant was involved in a non-work-related motor vehicle accident in February 2022. After a hearing in March 2022, the Industrial Accident Board (IAB) concluded that Mr. Hooten was able to work in a full-time, sedentary capacity and terminated total disability benefits. Mr. Hooten was placed on temporary partial disability. The claimant appealed, contending that the IAB committed legal error when it terminated benefits based upon the opinions of a medical expert who did not examine him after the subsequent accident.

The Superior Court confirmed that Delaware law permits medical expert opinions offered about a patient’s condition without a physical examination of that patient. Moreover, Dr. Gelman had reviewed all of Mr. Hooten’s medical records from both before and after the intervening accident. The court further reasoned that the claimant failed to timely notify the employer of the intervening accident or of the allegation of injuries to body parts in addition to the neck, in violation of IAB Rule 9(C)’s “thirty-day notice requirement.”

The court held that the two IAB decisions cited by the claimant were not controlling law. It explained that, while the IAB generally must follow its own case-decision precedent to avoid violations of due process, it is only bound to follow those decisions when they provide clear statements of law or policy. The court reasoned that the IAB decisions relied upon by the claimant were distinguishable from the facts/evidence of Mr. Hooten’s case because the physicians in those cases had not reviewed post-surgery records and there was no notice issue.

Lastly, the court determined that the record contained substantial evidence to support the IAB’s decision. The claimant’s condition did not appear to change at all initially following the February 2022 accident, according to his own testimony. Mr. Hooten, himself, was not credible because he claimed to be unable to drive in any capacity and then later admitted that he drives himself to medical appointments every day. The claimant’s testifying expert, Dr. Mann, was not credible because he did not testify clearly as to whether Mr. Hooten should be restricted from all work or only commercial driving. Mr. Hooten made no effort to find suitable employment and was not a displaced worker. The decision of the IAB was affirmed.

7.    The Superior Court affirmed a decision of the Industrial Accident Board that concluded Superior Court Civil Rule 41(a)(1)’s “Two Dismissal” rule did not apply to an IAB proceeding.
Hawkins v. United Parcel Service, 2023 WL 3749355 (Del. Super. Ct. May 30, 2023)

Mr. Hawkins was injured in a work accident on October 28, 2018. On December 9, 2019, the claimant filed a Petition to Determine Additional Compensation Due that sought total disability benefits and two surgeries, including a spine surgery. That petition was resolved (in conjunction with another) via a settlement of the parties in October 2020. On April 20, 2021, the claimant filed a Petition to Determine Additional Compensation Due that sought acknowledgment of two spine surgeries and a corresponding period of total disability. Before the hearing, the claimant voluntarily withdrew the petition. The claimant re-filed an identical petition on December 10, 2021. The employer moved to dismiss the petition on multiple bases, including that it was barred by (1) the doctrine of collateral estoppel, (2) the doctrine of res judicata, and (3) Superior Court Civil Rule 41(a)(1)’s “Two Dismissal” rule. If applied, the Two Dismissal rule would consider the voluntary dismissal of the April 20, 2021, petition to be an adjudication upon the merits as pertained to the spine surgery/temporary total disability issue.

The Industrial Accident Board (IAB) rejected the claimant’s arguments regarding collateral estoppel and res judicata because the issues and claims presented by the DACD were new and different from prior agreements between the parties. Additionally, the IAB explained that it is not bound by the Superior Court Rules of Civil Procedure. Its own rules and the rules of the Administrative Procedures Act did not include a similar provision and, accordingly, it did not regard the petition as dismissed with prejudice. The employer’s motion was denied. 

On appeal, the court agreed with the IAB’s conclusions. It reasoned that the IAB promulgates its own rules and cannot be forced to apply the Superior Court’s Rules of Procedure, even when there is no specific rule on point. The IAB is explicitly permitted to disregard customary rules of evidence and legal procedure so long as the disregard does not amount to an abuse of discretion. There was no abuse of discretion here, and the decision was affirmed.

8.    Industrial Accident Board concludes that regenerative medicine procedures, including orthobiologic injections, do not constitute “reasonable” or “necessary” treatment for a compensable lumbar spine condition.
Delfi v. State of Delaware, IAB No. 1481481 (Feb. 27, 2023)

Ms. Delfi injured her lumbar spine in a compensable work accident on January 7, 2019, while working as a bus driver for the State of Delaware. She came under the care of Dr. Bruce Rudin, an orthopaedic spine surgeon, shortly thereafter. After she did not improve from therapy, medications or steroid injections, Dr. Rudin believed her only options for improvement were an expensive, two-level fusion surgery or the less costly/invasive options afforded by regenerative medicine. The claimant proceeded with orthobiologic treatment procedures beginning in early 2020. The employer denied the treatment as not reasonable, necessary or causally related to the work accident based on the opinions of Dr. Scott Rushton. The claimant filed a Petition for Payment with the Industrial Accident Board (IAB).

The IAB concluded that the work accident aggravated pre-existing, asymptomatic low back issues, that the condition remained causally related to the work accident and felt that ongoing treatment of some kind was necessary. However, the option chosen did not satisfy either of the required “reasonableness” or “necessity” prongs for compensability. Dr. Rudin’s opinions were rejected for several reasons, including that he testified in 2020 that orthobiologic/regenerative medicine/stem cell treatment for the spine was approved and waiting finalization to be included in the Delaware Practice Guidelines, but now conceded it was not approved or even under consideration at this time; that the “study” relied upon by Dr. Rudin to support his methodology were his own, involved 100 patients and were not subject to peer review; that he provided no information about the methodology of his “study”; that he was an owner of Spine Care DE, where the orthobiologics procedures took place; that he does not perform surgeries anymore, which was the other option for the claimant; and that it was just as likely that the claimant’s sudden and significant weight loss improved her symptomatology as her treatment.

The IAB accepted Dr. Rushton’s opinions that there was a lack of scientific support for the methodology used by Dr. Rudin. Moreover, the IAB emphasized that there were strong indications of bias from the claimant’s expert, commenting that “Dr. Rudin’s experience and the close nature of his relationship, financially and otherwise, to acceptance of this methodology cannot be ignored.” The treatment was not reasonable in the context of the claimant’s injuries and the petition was denied.

9.    New workers’ compensation rates.

The Department of Labor announced that the new workers’ compensation rates effective July 1, 2023, establish an average weekly wage of $1,301.27. Accordingly, the maximum weekly compensation rate is $867.52 and the minimum weekly compensation rate is $289.18.

10.    Statistics from the Department of Labor.

The 25th Annual Report from the Department of Labor is available on the State’s website and provides updates, data and information that cover the year 2022.

Of note, Utilization Review requests decreased 29.32% in 2022, compared to 2021, and approximately 40.91% of those requests resulted in an appeal to the IAB, which was significantly lower than 2021. Chronic pain treatment continues to represent the most challenged treatment modality. In 2022, there were 2,124 active certified providers in Delaware, which represented a 36.86% decrease from 2021. Fewer petitions were filed and heard for the fifth consecutive year. However, there was an 18% increase in commutation settlements. Five-year cumulative statistics on appeals indicates the IAB has rendered 1,494 decisions, 208 of which were appealed. Sixty-nine decisions were affirmed, 30 were reversed or remanded, 81 were dismissed or withdrawn, and 26 were pending decision at the time of the report.


 

What’s Hot in Workers’ Comp, Vol. 27, No. 12, December 2023 is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. We would be pleased to provide such legal assistance as you require on these and other subjects when called upon. ATTORNEY ADVERTISING pursuant to New York RPC 7.1 Copyright © 2023 Marshall Dennehey, all rights reserved. No part of this publication may be reprinted without the express written permission of our firm. For reprints or inquiries, or if you wish to be removed from this mailing list, contact tamontemuro@mdwcg.com.

Firm Highlights

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.